• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Rapt Therapeutics Inc (NQ: RAPT )

    3.430 -0.200 (-5.51%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 185,688
    Open 3.620
    Bid (Size) 3.430 (5)
    Ask (Size) 3.990 (2)
    Prev. Close 3.630
    Today's Range 3.390 - 3.700
    52wk Range 2.610 - 27.35
    Shares Outstanding 34,358,152
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga

    Performance

    YTD
    -85.88%
    -85.88%
    1 Month
    +7.52%
    +7.52%
    3 Month
    -56.75%
    -56.75%
    6 Month
    -85.41%
    -85.41%
    1 Year
    -83.54%
    -83.54%

    More News

    Read More
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RAPT Therapeutics, Inc. and Encourages Investors to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
    Via Benzinga
    Exposures Product Safety
    RAPT Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    RAPT Therapeutics Reports First Quarter 2024 Financial Results
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    3 Biotech Stocks to Dump Before They Go to Zero
    Via InvestorPlace
    RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
    From RAPT Therapeutics, Inc.
    Via GlobeNewswire
    RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    What's Going On With RAPT Therapeutics Stock On Wednesday?
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Stocks Slip Ahead Of Fed Minutes, Nvidia Earnings
    Via Talk Markets
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
    Via Benzinga
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.